DEL POETA, GIOVANNI

DEL POETA, GIOVANNI  

Dipartimento di Biomedicina e Prevenzione  

Mostra records
Risultati 1 - 20 di 227 (tempo di esecuzione: 0.032 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-ago-2011 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia Dal Bo, M; Rossi, F; Rossi, D; Deambrogi, C; Bertoni, F; Del Giudice, I; Palumbo, G; Nanni, M; Rinaldi, A; Kwee, I; Tissino, E; Corradini, G; Gozzetti, A; Cencini, E; Ladetto, M; Coletta, A; Luciano, F; Bulian, P; Pozzato, G; Laurenti, L; Forconi, F; Di Raimondo, F; Marasca, R; DEL POETA, G; Gaidano, G; Foà, R; Guarini, A; Gattei, V Articolo su rivista
23-giu-2016 A case of SRSF2 mutation in chronic lymphocytic leukemia Garza, E; DEL POETA, G; Martinez Losada, C; Catalano, G; Borgia, L; Piredda, M; Fabiani, E; Gattei, V; LO COCO, F; Noguera, Ni Articolo su rivista
1-set-2016 A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature DEL PRINCIPE, Mi; Sarmati, L; Cefalo, M; Fontana, C; De Santis, G; Buccisano, F; Maurillo, L; De Bellis, E; Postorino, M; Sconocchia, G; DEL POETA, G; Sanguinetti, M; Amadori, S; Pagano, L; Venditti, A Articolo su rivista
1-gen-1998 A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias Cox, M; Maffei, L; Buffolino, S; DEL POETA, G; Venditti, A; Cantonetti, M; Aronica, G; Aquilina, P; Masi, M; Amadori, S Articolo su rivista
3-ott-2019 A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia Cohen, Ja; Rossi, Fm; Zucchetto, A; Bomben, R; Terzi-di-Bergamo, L; Rabe, Kg; Degan, M; Steffan, A; Polesel, J; Santinelli, E; Innocenti, I; Cutrona, G; D' Arena, G; Pozzato, G; Zaja, F; Chiarenza, A; Rossi, D; Di Raimondo, F; Laurenti, L; Gentile, M; Morabito, F; Neri, A; Ferrarini, M; Fegan, Cd; Pepper, Cj; Del Poeta, G; Parikh, Sa; Kay, Ne; Gattei, V Articolo su rivista
1-giu-1997 A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype Stasi, R; Bruno, A; Venditti, A; DEL POETA, G; Aronica, G; Cox, M; Maffei, L; Catalano, G; Zangrilli, D; Amadori, S Articolo su rivista
1-gen-2000 A novel t(11;12)(q23-24;q24) in a case of minimally-differentiated acute myeloid leukemia (AML-M0) Cox, M; Scanzani, A; DEL POETA, G; Venditti, A; Panetta, P; Derme, V; Sgro, R; Masi, M; Amadori, S Articolo su rivista
1-gen-2000 A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes Venditti, A; Tamburini, A; Buccisano, F; Scimo, M; DEL POETA, G; Maurillo, L; Cox, M; Abruzzese, E; Tribalto, M; Masi, M; Amadori, S Articolo su rivista
1-mag-2006 A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia Zucchetto, A; Bomben, R; Dal Bo, M; Sonego, P; Nanni, P; Rupolo, M; Bulian, P; Dal Maso, L; DEL POETA, G; DEL PRINCIPE, Mi; Degan, M; Gattei, V Articolo su rivista
1-giu-2012 A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia D'Arena, G; D'Auria, F; Simeon, V; Laurenti, L; Deaglio, S; Mansueto, G; DEL PRINCIPE, Mi; Statuto, T; Pietrantuono, G; Guariglia, R; Innocenti, I; Martorelli, M; Villani, O; De Feo, V; DEL POETA, G; Musto, P Articolo su rivista
1-nov-2005 Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia Degan, M; Zucchetto, A; Bomben, R; Dal Bo, M; Rupolo, M; Nanni, P; DEL POETA, G; Gattei, V Articolo su rivista
1-mar-2008 Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report Niscola, P; Scaramucci, L; Perrotti, A; Fratoni, S; Piccioni, D; Tendas, A; Cupelli, L; Dentamaro, T; DEL POETA, G; DE FABRITIIS, P Articolo su rivista
1-gen-1995 All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemia Venditti, A; Simone, M; DEL POETA, G; Stasi, R; Bruno, A; Venditti, A; Tribalto, M; Del Poeta, G; Amadori, S; Aronica, G; Bruno, A; Masi, M; Tribalto, M; Papa, G; Amadori, S Articolo su rivista
1-gen-1995 All-trans retinoic acid and low dose cytosine arabinoside for the treatment of "poor prognosis" acute myeloid leukemia Venditti, A; Stasi, R; DEL POETA, G; Buccisano, F; Bruno, A; Pisani, F; Caravita, T; Aronica, G; Masi, M; Stipa, E; Tribalto, M; Avvisati, G; Amadori, S; Papa, G Articolo su rivista
1-gen-1993 All-trans-retinoic acid plus low-doses of cytarabine for the treatment of poor-risk acute myeloid leukemias Venditti, A; Stasi, R; Masi, M; DEL POETA, G; Cox, C; Franchi, A; Piccioni, D; Bruno, A; Coppetelli, U; Tribalto, M; Papa, G Articolo su rivista
1-gen-1998 AML-M0: a biological and clinical profile Stasi, R; DEL POETA, G; Venditti, A; Cox, M; Abruzzese, E; Bruno, A; Buccisano, F; Tamburini, A; Pagano, A; Amadori, S Articolo su rivista
30-apr-1999 AML-M0: A review of laboratory features and proposal of new diagnostic criteria Stasi, R; Venditti, A; DEL POETA, G; Buccisano, F; Maurillo, L; DEL PRINCIPE, Mi; Riccitelli, A; Bruno, A; Cox Froncillo, M; Amadori, S Articolo su rivista
15-mar-2003 Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML) DEL POETA, G; Venditti, A; DEL PRINCIPE, Mi; Maurillo, L; Buccisano, F; Tamburini, A; Cox, M; Franchi, A; Bruno, A; Mazzone, C; Panetta, P; Suppo, G; Masi, M; Amadori, S Articolo su rivista
1-lug-2004 Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery Degan, M; Bomben, R; Bo, M; Zucchetto, A; Nanni, P; Rupolo, M; Steffan, A; Attadia, V; Ballerini, P; Damiani, D; Pucillo, C; DEL POETA, G; Colombatti, A; Gattei, V Articolo su rivista
1-gen-2008 Analysis of regulatory T cell changes in patients with idiopathic thrombocytopenic purpura receiving B-cell depleting therapy with rituximab Stasi, R; Cooper, N; DEL POETA, G; Stipa, E; Evangelista, M; Abruzzese, E; Amadori, S Articolo su rivista